SEC 13F Intelligence

Amalgamated Bank / TMO

Amalgamated Bank’s Thermo Fisher Scientific Inc Position

Does Amalgamated Bank own Thermo Fisher Scientific Inc (TMO)? Yes68.4K shares worth $34M (+0.26% of its 13F portfolio) as of Q1 2026, down from 69.8K shares the prior filed quarter.

Position Value
$34M
Q1 2026
Shares
68.4K
% of Portfolio
+0.26%
Quarters Held
29
currently held

Position History TMO

Reported value by quarter
Q1 ’19: $14MQ1 ’19Q2 ’19: $16MQ3 ’19: $18MQ4 ’19: $21MQ1 ’20: $18MQ1 ’20Q2 ’20: $9MQ3 ’20: $11MQ4 ’20: $11MQ1 ’21: $11MQ1 ’21Q2 ’21: $55MQ3 ’21: $60MQ4 ’21: $75MQ1 ’22: $63MQ1 ’22Q2 ’22: $54MQ3 ’22: $52MQ4 ’22: $57MQ1 ’23: $59MQ1 ’23Q2 ’23: $54MQ3 ’23: $51MQ4 ’23: $50MQ1 ’24: $48MQ1 ’24Q2 ’24: $43MQ3 ’24: $47MQ4 ’24: $38MQ1 ’25: $37MQ1 ’25Q2 ’25: $30MQ3 ’25: $35MQ4 ’25: $40MQ1 ’26: $34MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 202668.4K$34M+0.26%
Q4 202569.8K$40M+0.29%
Q3 202571.7K$35M+0.25%
Q2 202572.9K$30M+0.23%
Q1 202574.4K$37M+0.32%
Q4 202473.4K$38M+0.31%
Q3 202475.7K$47M+0.39%
Q2 202477.2K$43M+0.36%
Q1 202482.6K$48M+0.41%
Q4 202394.8K$50M+0.40%
Q3 2023100.0K$51M+0.43%
Q2 2023103.4K$54M+0.44%
Q1 2023102.7K$59M+0.50%
Q4 2022103.3K$57M+0.51%
Q3 2022102.7K$52M+0.50%
Q2 202299.9K$54M+0.51%
Q1 2022106.8K$63M+0.49%
Q4 2021112.7K$75M+0.55%
Q3 2021104.8K$60M+0.51%
Q2 2021108.8K$55M+0.44%
Q1 202123.2K$11M+0.40%
Q4 202024.2K$11M+0.43%
Q3 202024.3K$11M+0.47%
Q2 202024.9K$9M+0.42%
Q1 202064.1K$18M+0.44%
Q4 201965.9K$21M+0.39%
Q3 201963.1K$18M+0.39%
Q2 201954.4K$16M+0.37%
Q1 201951.7K$14M+0.34%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Amalgamated Bank’s full portfolio or all institutional holders of TMO.